Literature DB >> 18410994

The role of the basal ganglia in data processing.

James Leyden1, Tim Kleinig.   

Abstract

Complex cerebral activities are likely to be composed of massively repeated simple data processing tasks since the cortical data processing unit, the cortical mini-column, is found throughout the cortex with only minor variations. It has been proposed that one task performed by the cortical mini-column may be to match afferent sensory data to learnt datasets in a process known as automatic association. We hypothesize that basal ganglia circuits, through the relative signal of the nigro-striatal and striato-pallidal pathways, determine the matching threshold for dataset matching within cortical mini-columns. Basal ganglia circuits are in a unique position to use parallel information to modulate the parameters of auto-association to increase the speed of data processing tasks. This hypothesis can explain motor symptoms in Parkinson's disease and also predicts that over and underactivity of basal ganglia circuits (the 'on' and 'off' states) will lead to characteristic errors in sensory data interpretation in all modalities - false negative data recognition when 'off' and false positive data recognition when 'on'. As a preliminary exploration of this hypothesis 16 patients with advanced Parkinson's disease were tested in voice and face recognition when 'off' and 'on'. Each patient exhibited errors in the recognition task according to basal ganglia activity as predicted by our hypothesis. Further experiments to test the hypothesis are proposed.

Entities:  

Mesh:

Year:  2008        PMID: 18410994     DOI: 10.1016/j.mehy.2008.02.013

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

1.  Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis.

Authors:  Sonia Batista; Robert Zivadinov; Marietta Hoogs; Niels Bergsland; Mari Heininen-Brown; Michael G Dwyer; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2011-07-01       Impact factor: 4.849

2.  Neurocognitive phenotype of isolated methylmalonic acidemia.

Authors:  Colin J O'Shea; Jennifer L Sloan; Edythe A Wiggs; Maryland Pao; Andrea Gropman; Eva H Baker; Irini Manoli; Charles P Venditti; Joseph Snow
Journal:  Pediatrics       Date:  2012-05-21       Impact factor: 7.124

3.  Alterations of the salience network in obesity: a resting-state fMRI study.

Authors:  Isabel García-García; María Ángeles Jurado; Maite Garolera; Bàrbara Segura; Roser Sala-Llonch; Idoia Marqués-Iturria; Roser Pueyo; María José Sender-Palacios; Maria Vernet-Vernet; Ana Narberhaus; Mar Ariza; Carme Junqué
Journal:  Hum Brain Mapp       Date:  2012-04-21       Impact factor: 5.038

Review 4.  A key role of the basal ganglia in pain and analgesia--insights gained through human functional imaging.

Authors:  David Borsook; Jaymin Upadhyay; Eric H Chudler; Lino Becerra
Journal:  Mol Pain       Date:  2010-05-13       Impact factor: 3.395

5.  Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.

Authors:  D Damjanovic; P Valsasina; M A Rocca; M L Stromillo; A Gallo; C Enzinger; H E Hulst; A Rovira; N Muhlert; N De Stefano; A Bisecco; F Fazekas; M J Arévalo; T A Yousry; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-29       Impact factor: 3.825

6.  Vocal responses to perturbations in voice auditory feedback in individuals with Parkinson's disease.

Authors:  Hanjun Liu; Emily Q Wang; Leo Verhagen Metman; Charles R Larson
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

7.  [11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: A pilot study.

Authors:  So Yeon Jeon; Seongho Seo; Jae Sung Lee; Soo-Hee Choi; Do-Hyeong Lee; Ye-Ha Jung; Man-Kyu Song; Kyung-Jun Lee; Yong Chul Kim; Hyun Woo Kwon; Hyung-Jun Im; Dong Soo Lee; Gi Jeong Cheon; Do-Hyung Kang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.